Jacobs Levy Equity Management
KLRS

Jacobs Levy Equity Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Jacobs Levy Equity Management’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-28,888
Closed -$279K – 1226
2024
Q4 		$279K Buy
+28,888
New +$279K ﹤0.01% 877